CEO, Pulse Biosciences, Inc., Managing Partner and Chief Operating Officer, SV Health Investors, LLC Age: 68 Director Since: 2020 Edwards Board Role: Chair of the Compensation and Governance Committee Other Current Public Company Directorships: Pulse Biosciences, Inc., since 2024 Co-Chairman of the Board Other Public Company Directorships Previously Held: Misonix, Inc., from 2019 to 2021 Asensus Surgical, Inc. (formerly known as TransEnterix, Inc.), from 2014 to 2021 Thoratec Laboratories Corporation, from 2009 to 2015 Select Professional Experience and Highlights: Pulse Biosciences, Inc., a bioelectric medicine company, Chief Executive Officer, since 2025 SV Health Investors, LLC, a specialist healthcare fund management company, since 2009 Managing Partner and Chief Operating Officer, since 2014 Advanced Medical Technology Association (AdvaMed), an American medical device trade association, from 1998 to 2008 Boston Scientific Corporation, a medical device manufacturer, from 1994 to 2008 Various executive positions, including serving as Chief Operating Officer, from 2004 to 2008 C.R. Bard, Inc., a developer, manufacturer, and marketer of medical technologies, from 1984 to 1993 Various marketing and general management positions Kendall, Inc., a medical device manufacturer, from 1980 to 1984 Various marketing positions Medical Device Manufacturers Association, a national trade association providing educational and advisory assistance to medical technology companies Chairman of the Board, from 2016 to 2019 Innovation Advisory Board for the Mass General Brigham Health System Chairman of the Board, since 2015 Select Skills and Qualifications: As a result of his over 40 years in the medical technology industry, Mr. LaViolette brings extensive global executive experience. His many years of working with large, global organizations and start-ups, which he continues to do today, provides him with a unique perspective on strategy and innovation as well as corporate development. Mr. LaViolette also has experience in many other areas, including operations management, human capital resources, marketing and communications, corporate strategy and corporate governance. In addition, Mr. LaViolette s service on other boards, including numerous chairmanships, has enabled him to be a valuable contributor, offering astute insight in the strategic discussions at our Board and Compensation and Governance Committee meetings.